Fig. 5

In vivo anti-tumor activity of anti-miR-19a/FePS@PPF in HOS tumor-bearing mice. a Changes of tumor volume and b Body weights of mice at different time points after various treatments. c Photographs of tumors and d Tumor weights at day 14. e H&E, TUNEL and IHC staining of the tumor sections at the end of treatment. n = 5, **p < 0.01, G3, G5 and G6 compared to PBS (G1)